Overview of Kinemo, Inc.

Hands are still the default way we access our digital lives. But over 1.3M people in the U.S. cannot use their hands due to injury, neurological disease, or age-related limitations. That means losing independence in work, education, communication, and everyday tasks. The downstream impact is significant: unemployment rates are extremely high, and reduced access to digital tools compounds isolation that can lead to depression and even suicidal ideation. Device access is not a nice-to-have, it is a critical part for full participation in modern life.

Kinemo offers a wearable system with tiny motion sensors. Our sensors can capture any body movements and send these motion data to a compact controller. There, our motion AI model recognizes intended user gestures, and converts them into digital commands that are transmitted wirelessly to the target device. The result is hands-free control of smartphones, computers, gaming consoles, wheelchairs, robotic arms, and more.

We believe the future of human-device interaction is moving beyond screens and buttons, and accessibility is the most urgent, highest-signal place to build it. If Kinemo disappeared tomorrow, many of our users would lose the ability to text, work, play, and control their environment independently. Starting with accessibility also forces us to meet a higher bar for reliability and adaptability, which becomes a durable advantage as we expand into adjacent markets like sterile surgical rooms, industrial settings, and defense applications where augmenting control efficiency of drones can give our soldiers a battlefield edge by neutralizing enemy drones to reduce civilian casualties.

Momentum is building. 200+ clinical institutions have expressed interest, and 30+ clinical sites across the U.S. and Canada have already received a Kinemo device. These include Veterans Affairs centers, children’s hospitals, school districts, and rehabilitation centers. Our current wedge is clinician-driven adoption because it creates fast feedback loops, credible validation, and repeatable inbound demand from patient referrals.

We are still early since we launched our first device in September 2025, but we can see a repeatable sales pattern: clinical partner onboarding, patient identification, fitting and setup, and then follow-on demand as more patients ask for the same solution. We have only reached a tiny fraction (< 0.1%) of potential clinical customers so far, and the near-term goal is to leverage our existing clinical partners to reach more clinicians, and follow-up more consistently to increase our conversion rate.

We are also seeing strong industry validation. Amazon’s Accessibility Lab plans to feature Kinemo and promote it to smart-device makers. Microsoft’s Accessibility team is validating Kinemo with the goal of endorsing it as an officially approved Xbox controller. Google has approved Kinemo as an assistive tech vendor for Google employees worldwide. For us, these are early signals that there may be scalable distribution paths beyond purely clinician-led sales.

Our primary end-users are 1.3M Americans with limited hand function due to injury (spinal cord injury, traumatic brain injury), neurological disease (ALS, cerebral palsy, muscular dystrophy, multiple sclerosis), or age-related limitations (arthritis, carpal tunnel). After injury or disease diagnosis, the individual is evaluated by one of the 4,600 clinicians for assistive technology, typically a physical therapist, occupational therapist, speech language pathologist, or a rehabilitation engineer.

We have only reached a tiny fraction of assistive technology clinicians, so we would welcome collaborations with organizations who can help us expand to more clinical sites. Just as importantly, a key part of what we have achieved so far is building strong relationships with our clinical partners, relationships that can become the foundation for new assistive tech products that would help more patients. We would love to partner with groups who can bring ideas for technologies we could build using our company’s engineering skillsets, and we can leverage our growing clinical partner network as a distribution channel to pilot, validate, and commercialize those solutions.

We would love hands-on coaching to level up our sales process. We are two engineers, and we have learned enough to get early customers, but we want help turning interest into closed revenue more consistently. We also want to broaden beyond clinician-led distribution. Most potential end users do not consistently see a clinician, so we would benefit from guidance on a practical direct-to-consumer strategy. This may include how to raise awareness and market directly to end users.

We are raising a $1.2M seed round to build on our early traction and scale distribution. Specifically, we plan to (1) recruit two regional sales reps covering the East and West coasts to grow our clinical customer base and increase sales per clinical site, (2) increase brand recognition by exhibiting at industry tradeshows, (3) develop a subscription motion-analytics dashboard that provides actionable insights for clinicians, insurers, and users, and (4) pursue partnerships in adjacent human-device interface markets through customer discovery and preliminary data collection to support future non-dilutive grant applications (e.g., NIH, DoD).